AADAC antibody (N-Term)

Catalog No. ABIN2782106

Product Details anti-AADAC Antibody

Target: AADAC (Arylacetamide Deacetylase (Esterase) (AADAC))

Binding Specificity: N-Term

Reactivity: Human, Mouse, Rat, Horse, Dog, Guinea Pig, Rabbit

Host: Rabbit

Clonality: Polyclonal

Conjugate: This AADAC antibody is un-conjugated

Application: Western Blotting (WB)

Sequence: AHLKTIQNLA TFVELLGLHH FMDSFKVVGS FDEVPPTSDE NVTVTETKFN

Predicted Reactivity: Dog: 100%, Guinea Pig: 92%, Horse: 100%, Human: 100%, Mouse: 91%, Rabbit: 100%, Rat: 90%

Characteristics: This is a rabbit polyclonal antibody against AADAC. It was validated on Western Blot using a cell lysate as a positive control.

Purification: Affinity Purified

Immunogen: The immunogen is a synthetic peptide directed towards the N terminal region of human AADAC

Application Details

Application Notes: Optimal working dilutions should be determined experimentally by the investigator.

Comment:

Antigen size: 399 AA

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: Lot specific

Buffer: Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handling Advice: Avoid repeated freeze-thaw cycles.

Storage: -20 °C

Storage Comment: For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.

Target Details for AADAC

Target: AADAC (Arylacetamide Deacetylase (Esterase) (AADAC))

Alternative Name: AADAC (AADAC Products)

Background: Microsomal arylacetamide deacetylase competes against the activity of cytosolic arylamine N-acetyltransferase, which catalyzes one of the initial biotransformation pathways for arylamine and heterocyclic amine carcinogens.Microsomal arylacetamide deacetylase competes against the activity of cytosolic arylamine N-acetyltransferase, which catalyzes one of the initial biotransformation pathways for arylamine and heterocyclic amine carcinogens.Microsomal arylacetamide deacetylase competes against the activity of cytosolic arylamine N-acetyltransferase, which catalyzes one of the initial biotransformation pathways for arylamine and heterocyclic amine carcinogens. PRIMARYREFSEQ_SPAN PRIMARY_IDENTIFIER PRIMARY_SPAN COMP 1-5 AV705031.1 1-5 6-247 L32179.1 1-242 248-1725 BC032309.1 183-1660
Alias Symbols: CES5A1, DAC
Protein Size: 399

Molecular Weight: 46 kDa

Gene ID: 13

NCBI Accession: NM_001086, NP_001077

UniProt: P22760